1[1]Daniel G, Haller DG, Misset JL, et al. Docetaxel in advanced gastric cancer [ J ]. Anticancer Drugs, 2002, 13:451 - 460.
2[2]Rougier P. Docetaxel delivers new management opportunities for gastrointestinal carcinomas [ J ]. Anticancer Drugs, 1995, 6: 25-9.
3[3]Murad Am, petroianu A, Guimaraes Rc, et al. Phaes Ⅱ trial of the combinatin of Paclitaxel and 5-fluoruracil in the treatment of advanced gastric cancer: a novel, safe, and effective regimen[J]. Am J Clin Oncel, 1999, 22(6) :580-586.
4[4]BisseryMc, Nohynek G, Sanderink Gj, et al. Docetaxel ( TAXOTERE): a review of preclinical and clinical experience [J]. Anticancer Drugs, 1995, 6:339 - 355.
5Greta JL, Harold N, Shapiro J, et al. Phase I and pharmacokinetic trial of weekly oral fluorouracil given with eniluracil and low dose leucovorin to patients with solid tumors [J].J Clin Oncol, 2000.18(1):3952-3963.
6Lee JH. Lee JH. Ahn JH, el a]. Randomized trial of postoperative adjuvant therapy in stage Ⅱ and Ⅲ rectal cancer to define the optimal sequence of chemotherapy and radiotherapy: a preliminary report[J]. J Clin Oncol, 2009. 20(4): 1751-1758.
